Lov-D acyltransferase mediated acylation

US12060592B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12060592-B2
Application numberUS-202017089498-A
CountryUS
Kind codeB2
Filing dateNov 4, 2020
Priority dateSep 30, 2009
Publication dateAug 13, 2024
Grant dateAug 13, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods for the improved acylation of chemical substrates using LovD acyltransferases, thioesters having acyl groups, and (i) thiol scavengers and/or (ii) precipitating agents are presented. An improved method for the production of simvastatin using (i) activated charcoal as a thiol scavenger and/or (ii) ammonium hydroxide as a precipitating agent is also presented.

First claim

Opening claim text (preview).

What is claimed is: 1. A non-naturally occurring variant LovD polypeptide having at least two-fold greater acyltransferase activity than the wild-type Aspergillus terreus acyltransferase of SEQ ID NO: 2, which comprises a variant amino acid sequence of SEQ ID NO: 2 that includes a mutation at position 157 and from 1 to 30 additional mutations, as compared to SEQ ID NO: 2. 2. The non-naturally occurring variant LovD polypeptide of claim 1 , which has at least 10-fold greater acyltransferase activity than the wild-type A. terreus acyltransferase of SEQ ID NO: 2. 3. The non-naturally occurring variant LovD polypeptide of claim 1 , that includes the following additional mutations: A123P, N191S/G, A247S and L361M. 4. The non-naturally occurring variant LovD polypeptide of claim 3 , further comprising one or more additional mutations selected from: A9V, K26E, L192I, R250K, G275S, Q297E/G, and A383V. 5. The non-naturally occurring variant LovD polypeptide of claim 4 , wherein the one or more additional mutations are selected from: A9V, K26E, and G275S.

Assignees

Inventors

Classifications

  • Genes encoding for enzymes or proenzymes · CPC title

  • transferring groups other than amino-acyl groups (2.3.1) · CPC title

  • using catalysts, e.g. selective catalysts · CPC title

  • Acyltransferases (2.3) · CPC title

  • Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12060592B2 cover?
Methods for the improved acylation of chemical substrates using LovD acyltransferases, thioesters having acyl groups, and (i) thiol scavengers and/or (ii) precipitating agents are presented. An improved method for the production of simvastatin using (i) activated charcoal as a thiol scavenger and/or (ii) ammonium hydroxide as a precipitating agent is also presented.
Who is the assignee on this patent?
Codexis Inc
What technology area does this patent fall under?
Primary CPC classification C12P17/06. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).